UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 657

Sortiert nach

Reappraising the role of autologous transplantation for indolent B-cell lymphomas in the chemoimmunotherapy era: is it still relevant?

Bone marrow transplantation (Basingstoke), 2013-08, Vol.48 (8), p.1013-1021

HAMADANI, M

2013

Volltextzugriff (PDF)

Municipal solid waste management in China: a comparative analysis

Journal of material cycles and waste management, 2017-07, Vol.19 (3), p.1127-1135

2017

Volltextzugriff (PDF)

Development of ionic liquid-coated PLGA nanoparticles for applications in intravenous drug delivery

Nature protocols, 2023-08, Vol.18 (8), p.2509-2557

2023

Volltextzugriff (PDF)

Trends in pre- and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004-2014

Leukemia, 2017-09, Vol.31 (9), p.1998-2000

2017

Volltextzugriff (PDF)

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

Bone marrow transplantation (Basingstoke), 2017-02, Vol.52 (2), p.173-182

2017

Volltextzugriff (PDF)

Is myeloablative dose intensity necessary in allogeneic hematopoietic cell transplantation for lymphomas?

Bone marrow transplantation (Basingstoke), 2017-11, Vol.52 (11), p.1487-1494

2017

Volltextzugriff (PDF)

Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002

Bone marrow transplantation (Basingstoke), 2023-09

2023

Volltextzugriff (PDF)

Ionic Liquid Coating‐Driven Nanoparticle Delivery to the Brain: Applications for NeuroHIV

Advanced science, 2024-06, Vol.11 (23), p.e2305484-n/a

2024

Volltextzugriff (PDF)

Two decades of echinococcosis/hydatidosis research: Bibliometric analysis based on the web of science core collection databases (2000–2019)

Food and waterborne parasitology, 2021-12, Vol.25, p.e00137-e00137, Article e00137

2021

Volltextzugriff (PDF)

How we approach patient evaluation for hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2010-08, Vol.45 (8), p.1259-1268

2010

Volltextzugriff (PDF)

Lipid nanoparticle-mediated drug delivery to the brain

Advanced drug delivery reviews, 2023-06, Vol.197, p.114861-114861, Article 114861

2023

Volltextzugriff (PDF)

PHASE 3 RANDOMIZED STUDY OF LONCASTUXIMAB TESIRINE PLUS RITUXIMAB VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA – LOTIS‐5

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

Dispersive liquid–liquid microextraction based on the solidification of floating organic drop followed by ICP-MS for the simultaneous determination of heavy metals in wastewaters

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2015-04, Vol.140, p.156-161

2015

Volltextzugriff (PDF)

Managing Hodgkin lymphoma relapsing after autologous hematopoietic cell transplantation: a not-so-good cancer after all

Bone marrow transplantation (Basingstoke), 2014-05, Vol.49 (5), p.599-606

2014

Volltextzugriff (PDF)

Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies

Bone marrow transplantation (Basingstoke), 2013-10, Vol.48 (10), p.1279-1284

2013

Volltextzugriff (PDF)

Post-autologous transplant maintenance therapies in lymphoid malignancies: are we there yet?

Bone marrow transplantation (Basingstoke), 2015-11, Vol.50 (11), p.1393-1404

2015

Volltextzugriff (PDF)

Chronic GVHD and concurrent new-onset nephrotic syndrome in allogeneic transplant recipients. Incidence, pattern and therapeutic outcomes

Bone marrow transplantation (Basingstoke), 2015-03, Vol.50 (3), p.449-451

2015

Volltextzugriff (PDF)

Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infections

Bone marrow transplantation (Basingstoke), 2016-12, Vol.51 (12), p.1602-1604

2016

Volltextzugriff (PDF)

Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL)

Bone marrow transplantation (Basingstoke), 2017-02, Vol.52 (2), p.321-322

2017

Volltextzugriff (PDF)

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR PERIPHERAL T‐CELL LYMPHOMA: COMPARABLE OUTCOMES OF HAPLO‐IDENTICAL VS. MATCHED DONORS. A CIBMTR & EBMT ANALYSIS

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

P1717: HEALTH‐RELATED QUALITY OF LIFE AND TOLERABILITY OF LONCASTUXIMAB TESIRINE IN HIGH‐RISK PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED IN A PHASE 2 CLINICAL TRIAL (LOTIS 2)

HemaSphere, 2022-06, Vol.6 (Suppl), p.1598-1599

2022

Volltextzugriff (PDF)

LOTIS 2 FOLLOW‐UP ANALYSIS: UPDATED RESULTS FROM A PHASE 2 STUDY OF LONCASTUXIMAB TESIRINE IN RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft

Bone marrow transplantation (Basingstoke), 2017-01, Vol.52 (1), p.147-150

2017

Volltextzugriff (PDF)

CAMIDANLUMAB TESIRINE EFFICACY AND SAFETY IN AN OPEN‐LABEL, MULTICENTER, PHASE 2 STUDY OF PATIENTS (PTS) WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL)

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

P1104: A PHASE 1 STUDY EVALUATING SAFETY AND EFFICACY OF PARSACLISIB IN COMBINATION WITH BENDAMUSTINE + OBINUTUZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (CITADEL‐102)

HemaSphere, 2022-06, Vol.6 (Suppl), p.994-995

2022

Volltextzugriff (PDF)

1 – 25 von 657

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(498)
Mit Volltextzugriff
(621)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(333)
Life Sciences & Biomedicine
(289)
Humans
(233)
Female
(147)
Hematology
(136)
Male
(135)
Adult
(121)
Middle Aged
(109)
Transplantation
(109)
Aged
(90)
Immunology
(89)
Oncology
(75)
Young Adult
(58)
Hematology, Oncology And Palliative Medicine
(57)
Hematopoietic Stem Cell Transplantation
(53)
Hematopoietic Stem Cell Transplantation - Methods
(47)
Biological And Medical Sciences
(46)
Medicin Och Hälsovetenskap
(45)
Transplantation, Homologous
(45)
Infant
(44)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Biology Of Blood And Marrow Transplantation
(99)
Blood
(66)
Bone Marrow Transplantation
(28)
Journal Of Clinical Oncology
(28)
Transplantation And Cellular Therapy
(25)
Hematological Oncology
(20)
Blood Advances
(14)
Cancer
(12)
Clinical Lymphoma, Myeloma And Leukemia
(10)
Hemasphere
(8)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Reappraising the role of autologous transplantation for indolent B-cell lymphomas in the chemoimmunotherapy era: is it still relevant?

Municipal solid waste management in China: a comparative analysis

Development of ionic liquid-coated PLGA nanoparticles for applications in intravenous drug delivery

Trends in pre- and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004-2014

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

Is myeloablative dose intensity necessary in allogeneic hematopoietic cell transplantation for lymphomas?

Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002

Ionic Liquid Coating‐Driven Nanoparticle Delivery to the Brain: Applications for NeuroHIV

Two decades of echinococcosis/hydatidosis research: Bibliometric analysis based on the web of science core collection databases (2000–2019)

How we approach patient evaluation for hematopoietic stem cell transplantation

Lipid nanoparticle-mediated drug delivery to the brain

PHASE 3 RANDOMIZED STUDY OF LONCASTUXIMAB TESIRINE PLUS RITUXIMAB VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA – LOTIS‐5

Dispersive liquid–liquid microextraction based on the solidification of floating organic drop followed by ICP-MS for the simultaneous determination of heavy metals in wastewaters

Managing Hodgkin lymphoma relapsing after autologous hematopoietic cell transplantation: a not-so-good cancer after all

Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies

Post-autologous transplant maintenance therapies in lymphoid malignancies: are we there yet?

Chronic GVHD and concurrent new-onset nephrotic syndrome in allogeneic transplant recipients. Incidence, pattern and therapeutic outcomes

Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infections

Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL)

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR PERIPHERAL T‐CELL LYMPHOMA: COMPARABLE OUTCOMES OF HAPLO‐IDENTICAL VS. MATCHED DONORS. A CIBMTR & EBMT ANALYSIS

P1717: HEALTH‐RELATED QUALITY OF LIFE AND TOLERABILITY OF LONCASTUXIMAB TESIRINE IN HIGH‐RISK PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED IN A PHASE 2 CLINICAL TRIAL (LOTIS 2)

LOTIS 2 FOLLOW‐UP ANALYSIS: UPDATED RESULTS FROM A PHASE 2 STUDY OF LONCASTUXIMAB TESIRINE IN RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft

CAMIDANLUMAB TESIRINE EFFICACY AND SAFETY IN AN OPEN‐LABEL, MULTICENTER, PHASE 2 STUDY OF PATIENTS (PTS) WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL)

P1104: A PHASE 1 STUDY EVALUATING SAFETY AND EFFICACY OF PARSACLISIB IN COMBINATION WITH BENDAMUSTINE + OBINUTUZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (CITADEL‐102)

Suchergebnisse filtern